244 related articles for article (PubMed ID: 20398949)
1. Roles of trinucleotide-repeat RNA in neurological disease and degeneration.
Li LB; Bonini NM
Trends Neurosci; 2010 Jun; 33(6):292-8. PubMed ID: 20398949
[TBL] [Abstract][Full Text] [Related]
2. The molecular pathogenesis of repeat expansion diseases.
Fujino Y; Nagai Y
Biochem Soc Trans; 2022 Feb; 50(1):119-134. PubMed ID: 34940797
[TBL] [Abstract][Full Text] [Related]
3. RNA toxicity and foci formation in microsatellite expansion diseases.
Zhang N; Ashizawa T
Curr Opin Genet Dev; 2017 Jun; 44():17-29. PubMed ID: 28208060
[TBL] [Abstract][Full Text] [Related]
4. Trinucleotide repeat expansion in neurological disease.
La Spada AR; Paulson HL; Fischbeck KH
Ann Neurol; 1994 Dec; 36(6):814-22. PubMed ID: 7998766
[TBL] [Abstract][Full Text] [Related]
5. CAG-polyglutamine-repeat mutations: independence from gene context.
Ordway JM; Cearley JA; Detloff PJ
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1083-8. PubMed ID: 10434310
[TBL] [Abstract][Full Text] [Related]
6. The unstable repeats--three evolving faces of neurological disease.
Nelson DL; Orr HT; Warren ST
Neuron; 2013 Mar; 77(5):825-43. PubMed ID: 23473314
[TBL] [Abstract][Full Text] [Related]
7. The CAG/polyglutamine tract diseases: gene products and molecular pathogenesis.
Koshy BT; Zoghbi HY
Brain Pathol; 1997 Jul; 7(3):927-42. PubMed ID: 9217976
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Potential of Small Molecule-Based Therapeutic Approaches for Targeting Trinucleotide Repeat Disorders.
Verma AK; Khan E; Bhagwat SR; Kumar A
Mol Neurobiol; 2020 Jan; 57(1):566-584. PubMed ID: 31399954
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in molecular therapies for neurological disease: triplet repeat disorders.
Gonzalez-Alegre P
Hum Mol Genet; 2019 Oct; 28(R1):R80-R87. PubMed ID: 31227833
[TBL] [Abstract][Full Text] [Related]
10. Cellular toxicity of expanded RNA repeats: focus on RNA foci.
Wojciechowska M; Krzyzosiak WJ
Hum Mol Genet; 2011 Oct; 20(19):3811-21. PubMed ID: 21729883
[TBL] [Abstract][Full Text] [Related]
11. [Research progress in roles of microRNA in polyglutamine diseases].
Shi YT; Jiang H; Tang BS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Aug; 27(4):406-9. PubMed ID: 20677146
[TBL] [Abstract][Full Text] [Related]
12. Neurological diseases and RNA-directed gene regulation: prospects for new diagnostics and therapy.
Broude NE; Cantor CR
Expert Rev Mol Diagn; 2003 May; 3(3):269-74. PubMed ID: 12778999
[No Abstract] [Full Text] [Related]
13. Genetic and pharmacological suppression of polyglutamine-dependent neuronal dysfunction in Caenorhabditis elegans.
Parker JA; Holbert S; Lambert E; Abderrahmane S; Néri C
J Mol Neurosci; 2004; 23(1-2):61-8. PubMed ID: 15126693
[TBL] [Abstract][Full Text] [Related]
14. Repeat Expansion Disease Models.
Ueyama M; Nagai Y
Adv Exp Med Biol; 2018; 1076():63-78. PubMed ID: 29951815
[TBL] [Abstract][Full Text] [Related]
15. RNA toxicity induced by expanded CAG repeats in Huntington's disease.
Martí E
Brain Pathol; 2016 Nov; 26(6):779-786. PubMed ID: 27529325
[TBL] [Abstract][Full Text] [Related]
16. Polyglutamine expansion causes neurodegeneration by altering the neuronal differentiation program.
Abou-Sleymane G; Chalmel F; Helmlinger D; Lardenois A; Thibault C; Weber C; Mérienne K; Mandel JL; Poch O; Devys D; Trottier Y
Hum Mol Genet; 2006 Mar; 15(5):691-703. PubMed ID: 16434483
[TBL] [Abstract][Full Text] [Related]
17. Triplet repeats, RNA secondary structure and toxic gain-of-function models for pathogenesis.
Galvão R; Mendes-Soares L; Câmara J; Jaco I; Carmo-Fonseca M
Brain Res Bull; 2001 Oct-Nov 1; 56(3-4):191-201. PubMed ID: 11719250
[TBL] [Abstract][Full Text] [Related]
18. Expanded glutamines and neurodegeneration--a gain of insight.
Bates G
Bioessays; 1996 Mar; 18(3):175-8. PubMed ID: 8867730
[TBL] [Abstract][Full Text] [Related]
19. Comparative toxicity of polyglutamine, polyalanine and polyleucine tracts in Drosophila models of expanded repeat disease.
van Eyk CL; McLeod CJ; O'Keefe LV; Richards RI
Hum Mol Genet; 2012 Feb; 21(3):536-47. PubMed ID: 22021427
[TBL] [Abstract][Full Text] [Related]
20. Interferon mediated neuroinflammation in polyglutamine disease is not caused by RNA toxicity.
Bhambri A; Pinto A; Pillai B
Cell Death Dis; 2020 Jan; 11(1):3. PubMed ID: 31919387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
